The Journal of Neuroscience, March 15, 2000, 20(6):2409-2417
Novel Role for the NMDA Receptor Redox Modulatory Site in the
Pathophysiology of Seizures
Russell M.
Sanchez1,
Carl
Wang1,
Ginger
Gardner2,
Lianna
Orlando3,
David L.
Tauck4,
Paul A.
Rosenberg1, 3,
Elias
Aizenman5, and
Frances E.
Jensen1, 3
1 Department of Neurology, Children's Hospital and
Harvard Medical School, Boston, Massachusetts, 2 Department
of Obstetrics and Gynecology, Johns Hopkins Medical School, Baltimore,
Maryland, 3 Program in Neuroscience, Harvard Medical
School, Boston, Massachusetts, 4 Department of Biology,
Santa Clara University, Santa Clara, California, and
5 Department of Neurobiology, University of Pittsburgh
School of Medicine, Pittsburgh, Pennsylvania
Redox-active compounds modulate NMDA receptors
(NMDARs) such that reduction of NMDAR redox sites increases, and
oxidation decreases, NMDAR-mediated activity. Because NMDARs contribute to the pathophysiology of seizures, redox-active compounds also may
modulate seizure activity. We report that the oxidant
5,5'-dithio-bis(2-nitrobenzoic acid) (DTNB) and the redox cofactor
pyrroloquinoline quinone (PQQ) suppressed low
Mg2+-induced hippocampal epileptiform activity
in vitro. Additionally, in slices exposed to 4-7
µM bicuculline, DTNB and PQQ reversed the potentiation of
evoked epileptiform responses by the reductants dithiothreitol
and Tris(2-carboxyethyl)phosphine (TCEP). NMDA-evoked whole-cell
currents in CA1 neurons in slices were increased by TCEP and
subsequently decreased by DTNB or PQQ at the same concentrations that
modulated epileptiform activity. However, DTNB and PQQ had little
effect on baseline NMDA-evoked currents in control medium, and PQQ did
not alter NMDAR-dependent long-term potentiation. In contrast, in
slices returned to control medium after low
Mg2+-induced ictal activity, DTNB significantly
inhibited NMDAR-mediated currents, indicating endogenous reduction of
NMDAR redox sites under this epileptogenic condition. These data
suggested that PQQ and DTNB suppressed spontaneous ictal activity by
reversing pathological NMDAR redox potentiation without inhibiting
physiological NMDAR function. In vivo, PQQ decreased the
duration of chemoconvulsant-induced seizures in rat pups with no effect
on baseline behavior. Our results reveal endogenous potentiation of
NMDAR function via mass reduction of redox sites as a novel mechanism
that may enhance epileptogenesis and facilitate the transition to
status epilepticus. The results further suggest that redox-active
compounds may have therapeutic use by reversing NMDAR-mediated
pathophysiology without blocking physiological NMDAR function.
Key words:
NMDA receptor; redox; epilepsy; hippocampus; patch clamp; PQQ
Copyright © 2000 Society for Neuroscience 0270-6474/00/2062409-09$05.00/0